These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35577013)

  • 1. Cell-free DNA analysis for noninvasive examination of trisomy: comparing 2 targeted methods.
    Conotte S; El Kenz H; De Marchin J; Jani JC
    Am J Obstet Gynecol; 2022 Sep; 227(3):539-541. PubMed ID: 35577013
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating Cell-free DNA and Screening for Trisomies.
    Norton ME
    N Engl J Med; 2022 Oct; 387(14):1322-1324. PubMed ID: 36170494
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary cell-free DNA screening or contingent screening for the common trisomies: a response.
    Dar P; Norton ME
    Am J Obstet Gynecol; 2022 Jul; 227(1):127-128. PubMed ID: 35218698
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal reflex DNA screening for trisomy 21, 18 and 13.
    Wald NJ
    Expert Rev Mol Diagn; 2018 May; 18(5):399-401. PubMed ID: 29633889
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.
    Dar P; Jacobsson B; MacPherson C; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Edwards L; Haeri S; Silver R; Vohra N; Hyett J; Clunie G; Demko Z; Martin K; Rabinowitz M; Flood K; Carlsson Y; Doulaveris G; Malone C; Hallingstrom M; Klugman S; Clifton R; Kao C; Hakonarson H; Norton ME
    Am J Obstet Gynecol; 2022 Aug; 227(2):259.e1-259.e14. PubMed ID: 35085538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies.
    Rose NC; Barrie ES; Malinowski J; Jenkins GP; McClain MR; LaGrave D; Leung ML;
    Genet Med; 2022 Jul; 24(7):1379-1391. PubMed ID: 35608568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Review of Noninvasive Prenatal Testing: Experience from 551 Pregnancies with Noninvasive Prenatal Testing-Positive Results in a Tertiary Referral Center.
    Wu X; Li Y; Xie X; Su L; Cai M; Lin N; Du S; Xu L; Huang H
    J Mol Diagn; 2020 Dec; 22(12):1469-1475. PubMed ID: 33069877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening.
    Dervan AP; Deverka PA; Trosman JR; Weldon CB; Douglas MP; Phillips KA
    Genet Med; 2017 May; 19(5):559-567. PubMed ID: 27657682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient method for noninvasive prenatal diagnosis of fetal trisomy 13, trisomy 18, and trisomy 21.
    Sun X; Lu J; Ma X
    PLoS One; 2019; 14(4):e0215368. PubMed ID: 30978256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
    Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Outcomes of Infants with the Trisomy 13 or Trisomy 18 Syndromes.
    Carey JC
    J Pediatr; 2022 Aug; 247():11-13. PubMed ID: 35640673
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of non-invasive prenatal testing in preventing birth defects].
    Zhang W; Li S; Tang P; Wang J; Gu S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1061-1064. PubMed ID: 32924101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misdiagnosis of trisomy 13 and trisomy 18 is more common than anticipated.
    Geddes GC; Hafezi N; Gray BW
    Am J Med Genet A; 2022 Oct; 188(10):3126-3129. PubMed ID: 35924647
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenatal and fetal diagnosis of trisomy 18 after low-risk cell-free fetal DNA screening: A report of four cases.
    Sheehan E; Bacon V; Lascurain S; Stone J; Yatsenko S; Aarabi M; Skvarca LB; Clemens M; Saller D
    Prenat Diagn; 2023 Jan; 43(1):36-41. PubMed ID: 36426655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.
    Salomon LJ; Alfirevic Z; Audibert F; Kagan KO; Paladini D; Yeo G; Raine-Fenning N;
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):815-816. PubMed ID: 28573775
    [No Abstract]   [Full Text] [Related]  

  • 18. Prenatal reflex DNA screening for trisomies 21, 18, and 13.
    Wald NJ; Huttly WJ; Bestwick JP; Old R; Morris JK; Cheng R; Aquilina J; Peregrine E; Roberts D; Alfirevic Z
    Genet Med; 2018 Aug; 20(8):825-830. PubMed ID: 29120460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of fetal chromosomal aneuploidy diseases using noninvasive prenatal testing in twin pregnancies.
    Yu W; Lv Y; Yin S; Liu H; Li X; Liang B; Kong L; Liu C
    Expert Rev Mol Diagn; 2019 Feb; 19(2):189-196. PubMed ID: 30582381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-Free DNA Analysis in Maternal Blood: Differences in Estimates between Laboratories with Different Methodologies Using a Propensity Score Approach.
    Bevilacqua E; Jani JC; Letourneau A; Duiella SF; Kleinfinger P; Lohmann L; Resta S; Cos Sanchez T; Fils JF; Mirra M; Benachi A; Costa JM
    Fetal Diagn Ther; 2019; 45(5):302-311. PubMed ID: 29898450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.